Alnylam Pharmaceuticals, Inc.

Affiliations

  • Large Shareholder at Regulus Therapeutics Inc. (RGLS), 2014-10-28
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RGLS $16.29 446 $7,266.32 5,896,716 2014-10-24 Filing
RGLS $15.50 350 $5,425.49 5,897,162 2014-10-24 Filing
RGLS $14.63 1,054 $15,417.60 5,897,512 2014-10-24 Filing
RGLS $15.45 50 $772.50 5,898,566 2014-10-23 Filing
RGLS $14.90 450 $6,703.02 5,898,616 2014-10-23 Filing